Astria Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €202.07M +297.1% €3.82M -103.2% 1.9% +2.4 pp N/A N/A
    (estimated) €50.89M +1,040.7% -€119.44M -9.9% -234.7% +27 pp N/A N/A
    (estimated) €4.46M +24.5% -€132.62M +4.1% -2,972.8% +5.8 pp N/A N/A
    (estimated) €3.58M -69.3% -€127.41M +21.2% -3,556.4% -27 pp N/A N/A
    (estimated) €11.66M +∞% -€105.16M +30.8% -901.9% -9.0 pp N/A N/A
    €0.00 +NaN% -€80.40M +29.3% N/A -€68.99M +18.2% N/A
    €0.00 +NaN% -€62.17M +40.6% N/A -€58.36M +57.5% N/A
    €0.00 +NaN% -€44.21M +71.8% N/A -€37.05M +44.2% N/A
    €0.00 +NaN% -€25.74M -18.6% N/A -€25.70M -7.2% N/A
    €0.00 +NaN% -€31.61M +41.2% N/A -€27.68M +22.2% N/A
    €0.00 +NaN% -€22.38M +1.4% N/A -€22.65M +13.1% N/A
    €0.00 -100.0% -€22.07M -5.5% N/A -€20.03M -12.3% N/A
    €426.48K +∞% -€23.34M -24.1% -5,472.8% -55 pp -€22.84M -17.3% -5,355.8% -54 pp
    €0.00 +NaN% -€30.76M +10.5% N/A -€27.63M +10.3% N/A
    €0.00 +NaN% -€27.83M +49.1% N/A -€25.05M +45.5% N/A
    €0.00 +NaN% -€18.67M +20.8% N/A -€17.22M +23.7% N/A
    €0.00 +NaN% -€15.45M +115,529.6% N/A -€13.92M +107,125.9% N/A
    €0.00 -€13.36K N/A -€12.98K N/A

    Notifications